Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes

Yunpeng Cai,1,2 Mingxin Xu,2 Minglu Yuan,2 Zhenguo Liu,1 Weien Yuan2 1Department of Neurology, Xinhua Hospital, School of Medicine, 2School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People’s Republic of China Abstract: Since the availability of recombinant human growth hormo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cai Y, Xu M, Yuan M, Liu Z, Yuan W
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/9a7dc9e654854869abd3b5de20cb4578
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9a7dc9e654854869abd3b5de20cb4578
record_format dspace
spelling oai:doaj.org-article:9a7dc9e654854869abd3b5de20cb45782021-12-02T02:37:30ZDevelopments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes1178-2013https://doaj.org/article/9a7dc9e654854869abd3b5de20cb45782014-07-01T00:00:00Zhttp://www.dovepress.com/developments-in-human-growth-hormone-preparations-sustained-release-pr-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Yunpeng Cai,1,2 Mingxin Xu,2 Minglu Yuan,2 Zhenguo Liu,1 Weien Yuan2 1Department of Neurology, Xinhua Hospital, School of Medicine, 2School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People’s Republic of China Abstract: Since the availability of recombinant human growth hormone (rhGH) enabled the application of human growth hormone both in clinical and research use in the 1980s, millions of patients were prescribed a daily injection of rhGH, but noncompliance rates were high. To address the problem of noncompliance, numerous studies have been carried out, involving: sustained-release preparations, prolonged half-life derivatives, new injectors that cause less pain, and other noninvasive delivery methods such as intranasal, pulmonary and transdermal deliveries. Some accomplishments have been made and launched already, such as the Nutropin Depot® microsphere and injectors (Zomajet®, Serojet®, and NordiFlex®). Here, we provide a review of the different technologies and illustrate the key points of these studies to achieve an improved rhGH product. Keywords: intranasal, pulmonary, transdermal, microsphere, microneedle, hydrogelCai YXu MYuan MLiu ZYuan WDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 3527-3538 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Cai Y
Xu M
Yuan M
Liu Z
Yuan W
Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes
description Yunpeng Cai,1,2 Mingxin Xu,2 Minglu Yuan,2 Zhenguo Liu,1 Weien Yuan2 1Department of Neurology, Xinhua Hospital, School of Medicine, 2School of Pharmacy, Shanghai Jiao Tong University, Shanghai, People’s Republic of China Abstract: Since the availability of recombinant human growth hormone (rhGH) enabled the application of human growth hormone both in clinical and research use in the 1980s, millions of patients were prescribed a daily injection of rhGH, but noncompliance rates were high. To address the problem of noncompliance, numerous studies have been carried out, involving: sustained-release preparations, prolonged half-life derivatives, new injectors that cause less pain, and other noninvasive delivery methods such as intranasal, pulmonary and transdermal deliveries. Some accomplishments have been made and launched already, such as the Nutropin Depot® microsphere and injectors (Zomajet®, Serojet®, and NordiFlex®). Here, we provide a review of the different technologies and illustrate the key points of these studies to achieve an improved rhGH product. Keywords: intranasal, pulmonary, transdermal, microsphere, microneedle, hydrogel
format article
author Cai Y
Xu M
Yuan M
Liu Z
Yuan W
author_facet Cai Y
Xu M
Yuan M
Liu Z
Yuan W
author_sort Cai Y
title Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes
title_short Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes
title_full Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes
title_fullStr Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes
title_full_unstemmed Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes
title_sort developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/9a7dc9e654854869abd3b5de20cb4578
work_keys_str_mv AT caiy developmentsinhumangrowthhormonepreparationssustainedreleaseprolongedhalflifenovelinjectiondevicesandalternativedeliveryroutes
AT xum developmentsinhumangrowthhormonepreparationssustainedreleaseprolongedhalflifenovelinjectiondevicesandalternativedeliveryroutes
AT yuanm developmentsinhumangrowthhormonepreparationssustainedreleaseprolongedhalflifenovelinjectiondevicesandalternativedeliveryroutes
AT liuz developmentsinhumangrowthhormonepreparationssustainedreleaseprolongedhalflifenovelinjectiondevicesandalternativedeliveryroutes
AT yuanw developmentsinhumangrowthhormonepreparationssustainedreleaseprolongedhalflifenovelinjectiondevicesandalternativedeliveryroutes
_version_ 1718402306515402752